Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study
Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, et al.
PLoS Medicine (2021) Vol. 18, Iss. 10, pp. e1003820-e1003820
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 39
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials
Harrison J Hansford, Aidan G Cashin, Matthew D. Jones, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2336023-e2336023
Open Access | Times Cited: 28
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
Sarah Alabsi, Atharva Dhole, Sameh Hozayen, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 612-612
Open Access | Times Cited: 12
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
The implementation of target trial emulation for causal inference: a scoping review
Hanxiao Zuo, Lin Yu, Sandy Campbell, et al.
Journal of Clinical Epidemiology (2023) Vol. 162, pp. 29-37
Closed Access | Times Cited: 11
A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19
Amalia-Stefana Timpau, Radu-Ștefan Miftode, Daniela Leca, et al.
Life (2022) Vol. 12, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 14
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Peter A. C. Wing, Nathalie Schmidt, Rory Peters, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011323-e1011323
Open Access | Times Cited: 8
Mapping CircRNA–miRNA–mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection
Hassan Ayaz, Nouman Aslam, Faryal Mehwish Awan, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0283589-e0283589
Open Access | Times Cited: 6
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J. Bijlsma, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001674-e001674
Open Access | Times Cited: 5
Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomes
Zimo Chen, Jinglin Mo, Kaixuan Yang, et al.
The Innovation (2024) Vol. 5, Iss. 6, pp. 100713-100713
Open Access | Times Cited: 1
COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm
Max Bell, Anders Ekbom, Marie Linder
European Journal of Epidemiology (2023) Vol. 38, Iss. 3, pp. 301-311
Open Access | Times Cited: 3
Risk of Underlying Diseases and Effectiveness of Drugs on COVID-19 Inpatients Assessed Using Medical Claims in Japan: Retrospective Observational Study
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
International Journal of General Medicine (2023) Vol. Volume 16, pp. 657-672
Open Access | Times Cited: 3
Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication‐based sampling
Viktor H. Ahlqvist, Paul Madley‐Dowd, Amanda Ly, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 8, pp. 886-897
Open Access | Times Cited: 3
Critical Influenza and COVID-19—A Comparative Nationwide Case-Control Study
Emma Larsson, Jesper Eriksson, Mikael Eriksson, et al.
Critical Care Explorations (2022) Vol. 4, Iss. 5, pp. e0705-e0705
Open Access | Times Cited: 5
Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
F1000Research (2023) Vol. 12, pp. 398-398
Open Access | Times Cited: 2
Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19
Elena Izkhakov, Yair Vilian, Assaf Buch, et al.
BMC Geriatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients
Chris Gardiner, Ian Mackie, Peter MacCallum, et al.
International Journal of Laboratory Hematology (2022) Vol. 44, Iss. 5, pp. 817-822
Open Access | Times Cited: 4
Modifiable Risk Factors Are Important Predictors of COVID-19-Related Mortality in Patients on Hemodialysis
Jeroen P. Kooman, Paola Carioni, Vratislava Kovarova, et al.
Frontiers in Nephrology (2022) Vol. 2
Open Access | Times Cited: 4
Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
F1000Research (2024) Vol. 12, pp. 398-398
Open Access
Cardiovascular medications and its relations with COVID-19 survival
Sundas Butt, Dania M.N. Eltalib, Samina Alim, et al.
Elsevier eBooks (2024), pp. 39-63
Closed Access
Effects of Statins on Outcomes in Hispanic Patients with COVID-19
Seyed Khalafi, Justin Evans, Tyson Lumbreras, et al.
Journal of Investigative Medicine (2022) Vol. 70, Iss. 8, pp. 1697-1703
Closed Access | Times Cited: 3
Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Barrie Tan, Kok‐Yong Chin
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
Using Multi-Modal Electronic Health Record Data for the Development and Validation of Risk Prediction Models for Long COVID Using the Super Learner Algorithm
Weijia Jin, Wei Hao, Xu Shi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7313-7313
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top